HDAC inhibitor vorinostat enhances the antitumor effect of gefitinib in squamous cell carcinoma of head and neck by modulating ErbB receptor expression and reverting EMT
2010 · Journal of Cellular Physiology · 140 citations
https://doi.org/10.1002/jcp.22574